How Is Oncology Peptide Drug Development Creating New Therapeutic Classes?
Oncology peptide therapeutics — the application of tumor-targeting peptides, peptide-drug conjugates (PDCs), radiolabeled peptide receptor radionuclide therapy (PRRT), and cell-penetrating peptides delivering therapeutic payloads to tumor cells — creating a rapidly expanding therapeutic frontier within the Peptide Therapeutics Market, with PRRT representing the most commercially...
0 Kommentare 0 Geteilt 36 Ansichten 0 Bewertungen
Gesponsert